COVID-19 and myocarditis in competitive athletes | Medical News Bulletin 
Quick takes: Climate change impact, dengue in Bangladesh, hypervirulent recombinant coronavirus in cats 
After-action report finds that hepatitis A outbreak helped hone COVID-19 response – The San Diego Union-Tribune 
Ohio could drop below lowest COVID-19 cases in a year – NBC4 WCMH-TV 
The Search for Long Covid Treatments Takes a Promising Turn – WIRED 
When will the US have a Covid-19 vaccine for the youngest children? – CNN
CNN — It’s been more than a year since adults first got Covid-19 vaccines, but about 18 million children under...
Opinion | Covid Drugs Save Lives, but Americans Can’t Get Them – The New York Times
Almost two months after President Biden promised to make lifesaving drugs against Covid widely available to Americans, the medications remain...
Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 | MMWR – cdc.gov
On April 19, 2022, this report was posted online as an MMWR Early Release.Dallas S. Shi, MD, PhD1,2; Michael Whitaker,...
San Mateo: Nearly 90 students test positive for COVID-19 after prom – The Mercury News
SAN MATEO – Nearly 90 San Mateo High School students have tested positive for COVID-19 after attending prom earlier this...
WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator – World Health Organization
Today, WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19...
UK patient had COVID-19 for 505 days straight, study shows – The Associated Press – en Español
A U.K. patient with a severely weakened immune system had COVID-19 for almost a year and a half, scientists reported,...
Global COVID cases drop as pandemic disrupts routine US kids’ vaccines
In its weekly snapshot of the pandemic, the World Health Organization (WHO) said yesterday that global cases dropped for the...
AstraZeneca’s Evusheld slashes risk of symptomatic COVID-19 up to 83%
AstraZeneca's monoclonal antibody combination tixagevimab-cilgavimab (Evusheld) reduced the risk of symptomatic COVID-19 infection by 83% over placebo at a median...
News Scan for Apr 21, 2022
Patient contracted Omicron just 20 days after Delta strain of COVID-19A 31-year-old woman from Spain contracted COVID-19 twice within 3...
An mRNA vaccine with a twist—it copies itself—protects against COVID-19 – Science
A third messenger RNA (mRNA) vaccine appears to have proved its worth against COVID-19. And although it is more than...